| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 479 | 2017 |
| COVID-19: don't neglect antimicrobial stewardship principles! BD Huttner, G Catho, JR Pano-Pardo, C Pulcini, J Schouten Clinical Microbiology and Infection 26 (7), 808-810, 2020 | 430 | 2020 |
| Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH J Rodríguez-Baño, JR Pano-Pardo, L Alvarez-Rocha, Á Asensio, E Calbo, ... Enfermedades Infecciosas y Microbiología Clínica 30 (1), 22. e1-22. e23, 2012 | 321 | 2012 |
| Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical … JR Arribas, F Pulido, R Delgado, A Lorenzo, P Miralles, A Arranz, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (3), 280-287, 2005 | 214 | 2005 |
| European medical students: a first multicentre study of knowledge, attitudes and perceptions of antibiotic prescribing and antibiotic resistance OJ Dyar, C Pulcini, P Howard, D Nathwani, Esgap, ... Journal of Antimicrobial Chemotherapy 69 (3), 842-846, 2014 | 175 | 2014 |
| Severe odontogenic infections: epidemiological, microbiological and therapeutic factors R Sánchez, E Mirada, J Arias, JR Paño, M Burgueño Med Oral Patol Oral Cir Bucal 16 (5), e670-e676, 2011 | 171 | 2011 |
| Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document J Rodríguez-Baño, JR Paño-Pardo, L Alvarez-Rocha, A Asensio, E Calbo, ... Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad …, 2011 | 160 | 2011 |
| ESCMID COVID-19 living guidelines: drug treatment and clinical management M Bartoletti, O Azap, A Barac, L Bussini, O Ergonul, R Krause, ... Clinical Microbiology and Infection 28 (2), 222-238, 2022 | 155 | 2022 |
| Bacteraemia due to OXA‐48‐carbapenemase‐producing E nterobacteriaceae: a major clinical challenge C Navarro‐San Francisco, M Mora‐Rillo, MP Romero‐Gómez, ... Clinical Microbiology and Infection 19 (2), E72-E79, 2013 | 153 | 2013 |
| Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients JJ Castón, I Lacort-Peralta, P Martín-Dávila, B Loeches, S Tabares, ... International Journal of Infectious Diseases 59, 118-123, 2017 | 152 | 2017 |
| Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and … F Chaves, J Garnacho-Montero, JL Del Pozo, E Bouza, JA Capdevila, ... Medicina intensiva 42 (1), 5-36, 2018 | 145 | 2018 |
| Carbapenemase-producing Enterobacteriaceae in Spain in 2012 J Oteo, D Saez, V Bautista, S Fernández-Romero, JM Hernández-Molina, ... Antimicrobial agents and chemotherapy 57 (12), 6344-6347, 2013 | 140 | 2013 |
| Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza J Castilla, P Godoy, Á Domínguez, I Martínez-Baz, J Astray, V Martín, ... Clinical infectious diseases 57 (2), 167-175, 2013 | 128 | 2013 |
| Convalescent plasma for COVID-19: a multicenter, randomized clinical trial C Avendano-Sola, A Ramos-Martinez, E Munez-Rubio, B Ruiz-Antoran, ... MedRxiv, 2020.08. 26.20182444, 2020 | 118 | 2020 |
| Identification and susceptibility testing of microorganism by direct inoculation from positive blood culture bottles by combining MALDI-TOF and Vitek-2 Compact is rapid and … MP Romero-Gómez, R Gómez-Gil, JR Paño-Pardo, J Mingorance Journal of Infection 65 (6), 513-520, 2012 | 117 | 2012 |
| Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak JR Pano-Pardo, G Ruiz-Carrascoso, C Navarro-San Francisco, ... Journal of Antimicrobial Chemotherapy 68 (1), 89-96, 2013 | 115 | 2013 |
| Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain D Viasus, JR Paño‐Pardo, J Pachón, A Campins, F López‐Medrano, ... Clinical Microbiology and Infection 17 (5), 738-746, 2011 | 113 | 2011 |
| A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... Mayo Clinic Proceedings 91 (10), 1362-1371, 2016 | 101 | 2016 |
| Changes in causes of death over time after treatment for invasive aspergillosis JR Wingard, P Ribaud, HT Schlamm, R Herbrecht Cancer 112 (10), 2309-2312, 2008 | 100 | 2008 |
| A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia C Avendaño-Solá, A Ramos-Martínez, E Muñez-Rubio, B Ruiz-Antorán, ... The Journal of Clinical Investigation 131 (20), 2021 | 96 | 2021 |
